F.P.L. van Loon

559 total citations
11 papers, 400 citations indexed

About

F.P.L. van Loon is a scholar working on Endocrinology, Infectious Diseases and Epidemiology. According to data from OpenAlex, F.P.L. van Loon has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in F.P.L. van Loon's work include Vibrio bacteria research studies (6 papers), Viral gastroenteritis research and epidemiology (2 papers) and Escherichia coli research studies (2 papers). F.P.L. van Loon is often cited by papers focused on Vibrio bacteria research studies (6 papers), Viral gastroenteritis research and epidemiology (2 papers) and Escherichia coli research studies (2 papers). F.P.L. van Loon collaborates with scholars based in United States, Bangladesh and Sweden. F.P.L. van Loon's co-authors include David A. Sack, Geraldine M. McQuillan, Bagher Forghani, John D. Clemens, Deanna Kruszon‐Moran, Stephen C. Hadler, J. Chakraborty, Jan Holmgren, Malla Rao and Bradford A. Kay and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Gut.

In The Last Decade

F.P.L. van Loon

10 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.P.L. van Loon United States 8 213 138 115 66 55 11 400
P Pitisuttitham Thailand 10 122 0.6× 127 0.9× 170 1.5× 17 0.3× 62 1.1× 15 341
J. Colaert Belgium 13 230 1.1× 32 0.2× 115 1.0× 13 0.2× 15 0.3× 33 376
Rémi Forrat France 18 124 0.6× 51 0.4× 984 8.6× 37 0.6× 129 2.3× 37 1.5k
Mardi Reymann United States 13 106 0.5× 205 1.5× 254 2.2× 8 0.1× 16 0.3× 17 504
Simon Kerridge United Kingdom 7 63 0.3× 146 1.1× 248 2.2× 17 0.3× 9 0.2× 10 422
Biswajyoti Borkakoty India 15 244 1.1× 38 0.3× 220 1.9× 89 1.3× 18 0.3× 56 514
Michelle Dickey United States 9 189 0.9× 80 0.6× 222 1.9× 9 0.1× 37 0.7× 15 376
R. Schneerson United States 5 190 0.9× 174 1.3× 224 1.9× 9 0.1× 10 0.2× 5 520
Annelies Aerssens Belgium 12 146 0.7× 19 0.1× 173 1.5× 20 0.3× 73 1.3× 15 356
Gary Grohmann United States 9 296 1.4× 9 0.1× 267 2.3× 21 0.3× 72 1.3× 11 518

Countries citing papers authored by F.P.L. van Loon

Since Specialization
Citations

This map shows the geographic impact of F.P.L. van Loon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.P.L. van Loon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.P.L. van Loon more than expected).

Fields of papers citing papers by F.P.L. van Loon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.P.L. van Loon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.P.L. van Loon. The network helps show where F.P.L. van Loon may publish in the future.

Co-authorship network of co-authors of F.P.L. van Loon

This figure shows the co-authorship network connecting the top 25 collaborators of F.P.L. van Loon. A scholar is included among the top collaborators of F.P.L. van Loon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.P.L. van Loon. F.P.L. van Loon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kilgore, Paul E., Deanna Kruszon‐Moran, Jane F. Seward, et al.. (2003). Varicella in Americans from NHANES III: Implications for control through routine immunization. Journal of Medical Virology. 70(S1). S111–S118. 134 indexed citations
2.
Dykewicz, Clare A., Deanna Kruszon‐Moran, Geraldine M. McQuillan, et al.. (2001). Rubella Seropositivity in the United States, 1988–1994. Clinical Infectious Diseases. 33(8). 1279–1286. 24 indexed citations
3.
Loon, F.P.L. van, et al.. (2000). [Critical review of anti-influenza drugs].. PubMed. 144(4). 165–7. 1 indexed citations
4.
Loon, F.P.L. van, John D. Clemens, J. Chakraborty, et al.. (1996). Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine. 14(2). 162–166. 84 indexed citations
5.
Loon, F.P.L. van, et al.. (1993). Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. The Lancet. 341(8860). 1545–1550. 60 indexed citations
6.
Clemens, John D., David A. Sack, Malla Rao, et al.. (1993). The Design and Analysis of Cholera Vaccine Trials: Recent Lessons from Bangladesh. International Journal of Epidemiology. 22(4). 724–730. 14 indexed citations
7.
Loon, F.P.L. van. (1993). Cholera: developments in prevention and cure.. PubMed. 45(6). 269–73. 5 indexed citations
8.
Sack, David A., John D. Clemens, S. Huda, et al.. (1991). Antibody Responses after Immunization with Killed Oral Cholera Vaccines during the 1985 Vaccine Field Trial in Bangladesh. The Journal of Infectious Diseases. 164(2). 407–411. 42 indexed citations
9.
Loon, F.P.L. van, John D Clemens, David A. Sack, et al.. (1991). ABO Blood Groups and the Risk of Diarrhea Due to Enterotoxigenic Escherichia coli. The Journal of Infectious Diseases. 163(6). 1243–1246. 15 indexed citations
10.
Loon, F.P.L. van. (1990). Reply. Gut. 31(1). 123.2–123. 2 indexed citations
11.
Loon, F.P.L. van, et al.. (1990). Low gastric acid as a rise factor for cholera transmission: Application of a new non-invasive gastric acid field test. Journal of Clinical Epidemiology. 43(12). 1361–1367. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026